STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma
Lisa Evers(Translational Genomics Research Institute), Michael T. Barrett(Mayo Clinic in Arizona)
Cited by 28
Related Papers
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
|Nature Communications|2015|484
The association of genomic lesions and PD-1/PD-L1 expression in resected triple-negative breast cancers
|Breast Cancer Research|2018|84
Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
|Molecular Therapy Oncology|2025|3